Suzhou Zelgen Biopharmaceuticals Co.,Ltd   Report issue

For profit Phase 2 Phase 3
Founded: Suzhou China (2009)

Organization Overview

First Clinical Trial
2014
NCT02489916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Suzhou Zelgen Biopharmaceuticals Co.,Ltd